Broker Recommendations
Liberum reiterates 'buy' on IAG, lifts price target
Liberum reiterated its ‘buy’ recommendation on BA and Iberia owner IAG on Tuesday, and lifted its price target to 350p from 240p as it said positive earnings momentum was set to continue.
RBC Capital lifts Intertek to ‘sector perform’
RBC Capital Markets upgraded its stance on inspection, product testing and certification company Intertek on Tuesday to ‘sector perform’ from ‘underperform’ as it said the stock was close to fair value.
Berenberg stays at 'hold' on Vodafone, trims target price
Analysts at Berenberg reiterated their recommendation to 'hold' shares of Vodafone, arguing that the choice of Margherita Della Valle as the company's new chief executive officer reduced the risk of a dividend cut or of a warning on capital expenditures.
RBC Capital upgrades Spire Healthcare to 'outperform'
RBC Capital Markets upgraded Spire Healthcare on Friday to ‘outperform’ from ‘sector perform’ and lifted the price target to 270p from 230p on "signs of market acceleration".
Jefferies lifts Coca-Cola HBC price target
Jefferies upped its price target on shares of Coca-Cola Hellenic after the company’s first-quarter results, which it said were better than expected.
Berenberg describes Centamin's exploration programme as 'systematic' and 'disciplined'
Analysts at Berenberg reiterated their 'buy' recommendation and 145. 0p target price for shares of gold miner Centamin following an exploration roundtable with company management the day before.
Berenberg upgrades HSBC to 'buy'
Berenberg upgraded HSBC to ‘buy’ from ‘hold’ on Wednesday, keeping the price target at 780p, as it said the bank’s return on tangible equity of around 13% and attractive growth potential are undervalued.
Pearson not as exposed to AI as some of its rivals, says JPM
JP Morgan kept its 'overweight' rating on Pearson on Wednesday, arguing that the educational publisher is not as exposed to the potential threat of artificial intelligence as some of its rivals.
RBC Capital lifts Hikma price target, reiterates ‘outperform’
RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its ‘outperform’ rating.
Berenberg hikes price target on AJ Bell
Berenberg hiked its price target on AJ Bell on Tuesday to 370p from 300p, as it said resilient flows continue.
HSBC upgrades Rightmove to ‘buy’
HSBC upgraded Rightmove on Tuesday to ‘buy’ from ‘hold’ and lifted the price target to 645p from 530p as it said some of the early demand indicators show return of buyers’ interest and argued that positive sentiment from agents is not priced into current multiples for the stock.
Shore Capital downgrades JTC to ‘hold’
Shore Capital downgraded JTC on Tuesday to ‘hold’ from ‘buy’ as it lifted its fair value to 840p from 825p.